Articles from Micron Biomedical

$16M extension round led by J2 Ventures and GHIC builds on support from BARDA, CEPI, the Bill & Melinda Gates Foundation and others to simplify access to life-saving drugs
By Micron Biomedical · Via GlobeNewswire · January 16, 2025

U.S. Department of Health and Human Services (HHS) office, BARDA, awards Micron $2 million to continue its work on broadly-protecting avian and seasonal flu vaccines
By Micron Biomedical · Via GlobeNewswire · January 14, 2025

U.S. Department of Health and Human Services (HHS) office, BARDA, awards Micron $2 million to continue its work on broadly-protecting avian and seasonal flu vaccines
By Micron Biomedical · Via GlobeNewswire · January 13, 2025

CEPI grant aims to build on evidence of Micron Biomedical’s needle-free delivery of vaccines to bring CastleVax’s novel rapid-response platform to the clinic
By Micron Biomedical · Via GlobeNewswire · January 8, 2025

ATLANTA, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, today announced the company secured a $7.5 million grant from the Bill & Melinda Gates Foundation that brings total grant funding from the organization to $43 million.
By Micron Biomedical · Via GlobeNewswire · January 7, 2025